<DOC>
	<DOCNO>NCT00394563</DOCNO>
	<brief_summary>The purpose study look effect RN624 moderate severe knee pain due osteoarthritis . This study look safety pain relieve effect RN624 compare placebo 4 month period .</brief_summary>
	<brief_title>A Phase II Study Looking Moderate Severe Osteoarthritis Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Male nonpregnant female age 4075 chronic moderate severe knee pain due OA ( score 50 100 visual analog scale knee pain ) . Subjects must meet one follow : unwilling take nonopiate pain medication , nonopiate pain medication fail , candidate seek invasive intervention intraarticular injection , knee arthroplasty , total knee surgery History symptom autoimmune disorder , cancer within last 5 year except cutaneous basal cell squamous cell cancer resolve excision , allergic reaction monoclonal antibody IgGfusion protein , Hepatitis B , C HIV , drug abuse , fibromyalgia , clinically significant cardiac disease , diabetes mellitus require oral treatment insulin , clinically significant neurological disease clinically significant psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>osteoarthritis monoclonal antibody</keyword>
</DOC>